Feladilimab (Anti-ICOS / CD278)

Ask supplier a question | View on supplier's website

Feladilimab (Anti-ICOS/CD278) is humanized IgG4 anti-ICOS agonist monoclonal antibody. Feladilimab binds to ICOS-expressing T cells. Feladilimab has potential for its use in cancer research. MW: 145.5 KD.

Supplier	Selleck Chemicals
Product #	A2462
Sku #	A2462-1mg*5
Pricing	1mg*5, $790.00

Feedback